-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 28, Chuangsheng Group announced that its Claudin18.
Biliary tract cancer is a rarer malignancy, including bile duct cancer and gallbladder cancer
This study is an open-label, single-arm, multicenter Phase IIa clinical study in patients with locally advanced or metastatic biliary tract cancer who have not received systemic therapy to evaluate the safety, tolerability, and antibacterial properties of TST001.
TST001 is a high-affinity humanized monoclonal antibody targeting Claudin18.
(Original abridged)